A case of effective use of alemtuzumab in a male patient with T-cell lymphoma

  • Authors: Sokolov AN1, Parovichnikova EN1, Isaev VС1, Ustinova ЕN1, Shavlokhov VS1, Atopkov VA1, Model SV1, Tsyba NN1, Kaplanskaya IВ1, Klyasova GA1, Aleksanyan MZ.1, Vishnevskaya ES1, Togonidze DK1, Mirzoyan EE1, Savchenko VG1
  • Affiliations:
  • Issue: Vol 79, No 12 (2004)
  • Pages: 73-75
  • Section: Editorial
  • URL: https://ter-arkhiv.ru/0040-3660/article/view/29971
  • Cite item

About the authors

A N Sokolov

E N Parovichnikova

V С Isaev

Е N Ustinova

V S Shavlokhov

V A Atopkov

S V Model

N N Tsyba

I В Kaplanskaya

G A Klyasova

M Zh Aleksanyan

E S Vishnevskaya

D K Togonidze

E E Mirzoyan

V G Savchenko

References

  1. Hale G., Dyer M. J., Waldmann H. et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1988; 2 (8625): 1394-1399.
  2. Dearden С. E., Matutes E., Catovsky D. Alemtuzumab in T-cell malignancies. Med. Oncol. 2002; 19 (suppl): S27-S32.
  3. Dearden С. E., Dyer M. J., Catovsky D. et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001; 98(6): 1721-1726.
  4. Hainsworth J. D. Monoclonal antibody therapy in lymphoid malignancies. Oncologist 2000; 5(5): 376-384.
  5. Keating M. New drugs in hematologic malignancies. Haematologica 2001; 86(N 11, suppl.): 40-42.
  6. Воробьев А. И., Виноградова Ю. Э. В кн. Воробьев А. И. (ред.) Руководство по гематологии. М.; 2003: 57-63, 113-131.
  7. Воробьев А. И., Кременецкая А. М., Лорие Ю. Ю. "Старые" и "новые" опухоли лимфатической системы. Тер. арх. 2000; 7: 9-13.
  8. Jaffe E. S., Harris N. L., Stein H., Wordiman J. W. Pathology and genetics of tumors and of haemopoietic and lymphoid tissues. WHO classifications of tumors. Lyon: IRCS Press; 2001.
  9. Birhiray R. E., Shaw C., Brettman L. et al. Phenotypic transformation of CD52 (pos) to CD52 (neg) leukemic T-cell as a mechanism for resistance to CAMPATH-1H. Leukemia 2002; 16 (5): 861-864.

Statistics

Views

Abstract - 47

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies